MAY 24, 2016 3:32 AM PDT

Nanomedicine Delivers Chemotherapy Drugs to Brain Tumors

WRITTEN BY: Xuan Pham

By packing chemotherapy drugs in nanoscale lipid droplets, researchers say they may have found a new way to treat one of the deadliest forms of primary brain cancer known as glioblastoma multiforme (GBM). Nanotheraputics, as this field of medicine is now called, combines nanotechnology, chemistry, and bioengineering into a remarkable system with seemingly “endless and bright” possibilities, said Ann-Marie Broome, senior author of the newly published study.

 
Image credit: Pixabay.com
 

 Dubbed as the “octopus tumor,” GBMs are characterized with malignant glial cells forming vast networks of tendrils throughout the brain. This makes it nearly impossible to surgically remove all the cancerous tissues. As such, this brain cancer can evade even the most aggressive surgeries, chemotherapies, and radiotherapies, leaving patients with a five-year survival rate of less than 10 percent.
 
Another part of the reason why chemotherapy is ineffective against GBM is the blood-brain barrier (BBB). Designed to protect the brain from the environment, the BBB also prevents drugs from passing through to act on the GBM cancer cells.
 
To breach the BBB, Broome and her team aimed at creating nanocarriers that could ferry drugs into the brain. They designed a micelle – “a bit of fat globule” – that was so small it easily slipped past the BBB. Inside the micelle, the team packaged the chemotherapy drug, temozolomide (TMZ).
 
"Micelles of a certain size will cross the blood-brain barrier carrying a concentrated amount of TMZ," Broome said. To the micelles, they also incorporated platelet-derived growth factors (PDGF), which are proteins that are overexpressed in the cancer cells. "The PDGF is used much like a postal address. The micelle gets it to the street, and the PDGF gets it to the house."
 
Once inside the cancer, the team exploited cancer’s unnatural acidic environment to trigger the release of the drug. "We take advantage of the tumor's natural environment as well as the cellular expression. I'm a big proponent of understanding that microenvironment has an impact on how well you can treat tumors. It's probably why so many therapeutics fail - because you have to take into account the immune system, the local environment, and the cells themselves - all three of these are important considerations."
 
In experiment results, this method worked so well that Broome initially questioned her results. "I was very surprised by how efficiently and well it worked once we got the nanocarrier to those cells," said Broome. But after many validation experiments in different cell lines and using different drug concentrations, the results still proved promising.
 
In the next phase, Broome anticipates more testing with different drugs and other biomarkers for GBM. "[TMZ] may or may not be effective for all types of GBMs. There are subtypes as well as therapeutic-resistant GBMs that these nanocarriers may not impact. We need to continue rigorous testing to verify and validate our initial findings."
 
But for now, the team is excited for the possibilities that have opened up with this nanotherapeutics technology. 
 


Additional source: Medical University Of South Carolina news release

About the Author
I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 10, 2022
Neuroscience
Scientists Develop Neurobiological Model to Explore Creativity and Neural Networks
JUN 10, 2022
Scientists Develop Neurobiological Model to Explore Creativity and Neural Networks
A study published in Neuroscience found that different areas of the brain are activated depending on the type of creativ ...
JUN 21, 2022
Cancer
Advanced Lung Cancer Diagnosis Linked to Socioeconomic Status
JUN 21, 2022
Advanced Lung Cancer Diagnosis Linked to Socioeconomic Status
Lung cancer remains the leading cause of cancer-related deaths for both males and females, and an estimated 120,000 peop ...
JUL 28, 2022
Clinical & Molecular DX
Pancreatic Cancer is Difficult to Detect in its Curable Early Stages: AI Could Soon Change This
JUL 28, 2022
Pancreatic Cancer is Difficult to Detect in its Curable Early Stages: AI Could Soon Change This
Pancreatic cancer typically does not cause symptoms until after it has spread to other organs. This makes it very diffic ...
AUG 01, 2022
Drug Discovery & Development
New drug could help repair nervous system damage caused by strokes
AUG 01, 2022
New drug could help repair nervous system damage caused by strokes
A recent study published in Cell Reports highlights a new drug that could help to repair nervous system damage caused by ...
AUG 03, 2022
Clinical & Molecular DX
Monkeypox Updates: Transmission, Symptoms, and Treatment
AUG 03, 2022
Monkeypox Updates: Transmission, Symptoms, and Treatment
With the 2020 Covid lockdowns still fresh in our minds, the recent outbreak of monkeypox in the United States has many p ...
AUG 10, 2022
Technology
Microrobotics for Endodontic Root Canal Treatment and Diagnosis
AUG 10, 2022
Microrobotics for Endodontic Root Canal Treatment and Diagnosis
Root canal, anyone? With a reputation for being one of the most dreaded dental procedures, root canal treatment involves ...
Loading Comments...